
6-MP Tablet
$0.26 / unit
Available Options
| Pack Size | Price | Price / Unit | Quantity | Action |
|---|---|---|---|---|
| 180 Tablets | $35.00 | $0.19/unit | ||
| 150 Tablets | $30.00 | $0.20/unit | ||
| 120 Tablets | $24.00 | $0.20/unit | ||
| 90 Tablets | $19.00 | $0.21/unit | ||
| 60 Tablets | $14.00 | $0.23/unit | ||
| 30 Tablets | $8.00 | $0.27/unit |
Product Description
What is this medicine?
6-MP TABLET contains Mercaptopurine 50 mg, also known as 6-mercaptopurine (6-MP). It is an antimetabolite / purine analogue anticancer medicine used mainly in the treatment of certain blood cancers.
Current Indian product information identifies 6-MP 50 mg Tablet as containing Mercaptopurine 50 mg and being marketed by Zydus Lifesciences Ltd..
Mercaptopurine interferes with the formation of DNA and RNA in rapidly dividing cells. This slows or stops the multiplication of abnormal blood cells.
This medicine is commonly used for:
acute lymphoblastic leukemia (ALL)
maintenance treatment of ALL
certain other leukemias when prescribed by an oncology specialist
combination chemotherapy regimens involving mercaptopurine
Mercaptopurine is particularly well established as part of maintenance therapy for acute lymphoblastic leukemia.
6-MP is a potent prescription anticancer medicine and should only be used under the supervision of an oncologist or other appropriately qualified specialist.
What should I tell my health care provider before I take this medicine?
They need to know if you have any of these conditions:
allergy to mercaptopurine
allergy to any ingredient in the tablet
liver disease
kidney disease
bone marrow problems
low white blood cell count
low platelet count
anemia
current or recurrent infection
previous serious infection
pancreatitis
previous severe reaction to mercaptopurine
previous treatment with chemotherapy
previous radiation therapy
TPMT deficiency
NUDT15 deficiency
pregnant or trying to get pregnant
breast-feeding
Tell your healthcare provider if you have previously taken azathioprine, because azathioprine is metabolized to mercaptopurine.
Before and during treatment, your healthcare provider may perform blood tests to check:
complete blood count
white blood cell count
platelet count
liver function
kidney function
Some patients have genetic differences in TPMT or NUDT15 enzymes that can substantially increase the risk of severe mercaptopurine toxicity. Your healthcare provider may consider testing or dose adjustment when appropriate.
Tell your healthcare provider about all prescription medicines, non-prescription medicines, vitamins, herbal products and dietary supplements you use.
How should I use this medicine?
Take 6-MP TABLET by mouth exactly as directed by your oncologist or healthcare professional.
The dose of mercaptopurine is individualized. It may depend on:
body weight or body surface area
type of leukemia
treatment protocol
blood-cell counts
liver function
kidney function
TPMT or NUDT15 activity
other chemotherapy medicines
response to treatment
treatment-related toxicity
Take your doses at regular intervals.
Current Indian information for 6-MP 50 mg states that the medicine may be taken with or without food, while the exact dose and frequency should be determined by the treating doctor.
Because food can affect mercaptopurine exposure, follow your oncology team's instructions consistently regarding meals.
Do not:
change your dose yourself
take more tablets than prescribed
stop treatment without consulting your oncologist
change the timing of treatment without medical advice
Overdosage: If you think you have taken too much mercaptopurine, contact your oncologist or emergency medical service immediately. Overdose can cause serious bone-marrow suppression, gastrointestinal symptoms and liver toxicity.
NOTE: This medicine is only for you. Do not share this medicine with others.
What if I miss a dose?
If you miss a dose of 6-MP, follow the instructions provided by your oncology team.
If you are unsure what to do, contact your doctor, oncology nurse or pharmacist.
Do not:
take two doses together
double the next dose
take extra tablets to compensate for a missed dose
Maintaining the prescribed treatment schedule is particularly important during leukemia maintenance therapy.
Repeatedly missing mercaptopurine doses can reduce treatment effectiveness; adherence to 6-MP during ALL maintenance therapy has been associated with relapse risk.
What may interact with this medicine?
Tell your healthcare provider if you take:
allopurinol
febuxostat
azathioprine
warfarin
mesalamine
sulfasalazine
olsalazine
other chemotherapy medicines
medicines that suppress bone marrow
medicines that affect liver function
certain immunosuppressive medicines
Important allopurinol interaction
Allopurinol can substantially increase mercaptopurine exposure and toxicity.
If both medicines are required, the mercaptopurine dose generally needs significant adjustment by a specialist.
Do not start allopurinol or another uric-acid-lowering medicine without informing the doctor managing your mercaptopurine treatment.
Vaccines
Tell your healthcare provider before receiving any vaccination.
Because mercaptopurine can suppress the immune system, live vaccines may need to be avoided during treatment.
This list may not describe all possible interactions.
Give your healthcare provider a list of all medicines, herbs, non-prescription drugs, vitamins and dietary supplements you use.
What should I watch for while using this medicine?
Visit your oncologist or healthcare professional for regular checks on your progress.
Regular laboratory monitoring is very important during mercaptopurine treatment.
Bone marrow suppression
Mercaptopurine can reduce the production of blood cells.
Contact your healthcare provider if you develop:
fever
chills
persistent sore throat
unusual tiredness
unusual weakness
unexplained bruising
unusual bleeding
frequent infections
Infection
Mercaptopurine can lower your body's ability to fight infections.
Avoid unnecessary close contact with people who have contagious illnesses and report signs of infection promptly.
Liver problems
Your healthcare provider may regularly monitor your liver function.
Contact your doctor if you develop:
yellowing of the skin or eyes
dark urine
severe or persistent nausea
unusual tiredness
upper abdominal pain
loss of appetite
Pancreatitis
Seek medical attention if you develop severe or persistent abdominal pain, particularly if accompanied by nausea or vomiting.
Sun exposure
Long-term immunosuppressive treatment may increase susceptibility to certain skin cancers.
Protect your skin from excessive sunlight and UV exposure. Use protective clothing and appropriate sunscreen when outdoors.
What side effects may I notice from this medicine?
Side effects that you should report to your doctor or health care professional as soon as possible:
fever or chills
persistent sore throat
signs of serious infection
unusual bleeding or bruising
severe weakness or tiredness
pale skin
severe abdominal pain
persistent nausea or vomiting
yellowing of the skin or eyes
dark urine
severe diarrhea
mouth ulcers
severe skin reaction
severe allergic reaction
swelling of the face, lips, tongue or throat
difficulty breathing or swallowing
Side effects that usually do not require immediate medical attention but should be reported if they continue or are bothersome:
nausea
vomiting
loss of appetite
diarrhea
stomach discomfort
mouth sores
tiredness
skin rash
Blood tests may also show:
low white blood cell count (leukopenia)
low neutrophil count
low platelet count
anemia
changes in liver enzymes
Because bone-marrow suppression can become serious, regular blood testing is an essential part of mercaptopurine treatment.
This list may not describe all possible side effects.
Where should I keep my medicine?
Keep 6-MP TABLETS out of the reach of children.
Current Indian product information identifies:
Brand Name: 6-MP 50 mg Tablet
Generic Name: Mercaptopurine / 6-Mercaptopurine
Strength: 50 mg
Dosage Form: Tablet
Therapeutic Class: Antineoplastic / Antimetabolite / Purine Analogue
Marketer: Zydus Lifesciences Ltd.
Pack Size: 10 tablets in the current retail listing
Route: Oral
Primary Use: Treatment/maintenance therapy of certain leukemias, particularly Acute Lymphoblastic Leukemia (ALL)
Country: India
Regulatory Status: Prescription anticancer medicine
Storage: Store below 25°C according to current Indian product information.
Keep the tablets:
in their original blister or container
protected from excessive heat
protected from moisture
away from direct sunlight
Follow the exact storage and handling instructions printed on the original 6-MP packaging.
Because mercaptopurine is a cytotoxic/anticancer medicine, handle it carefully and follow any specific handling instructions provided by your pharmacist or oncology team.
Do not use tablets that are damaged or have changed significantly in colour, appearance or physical condition.
Do not use 6-MP Tablets after the expiration date printed on the blister or outer packaging.




